Diabetic amyotrophy: a follow-up study.
A clinical follow-up study of 12 patients with diabetic amyotrophy is reported. Re-examination after an interval indicated that improvement had occurred in all but one instance, and had been maintained over an average follow-up period of four and a half years. Improvement in the neurological syndrome appeared to follow improvement in diabetic control or institution of treatment in those whose diabetes had not previously been diagnosed.Seven patients made a good functional recovery, three no longer having any muscular weakness. Five showed significant residual disability.
D000200:Action Potentials; D000368:Aged; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D048909:Diabetes Complications; D003929:Diabetic Neuropathies / Q000628:therapy*; D003927:Diet, Diabetic; D004568:Electrodiagnosis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009133:Muscular Atrophy / Q000628:therapy*
D002556:Cerebrospinal Fluid Proteins; D007328:Insulin